BNGO News and Press, Bionano Genomics Inc. From 03/15/21

SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the following investor conferences: Oppenheimer 31 st Annual Healthcare Conference , March 16-18, 2021 º ...

SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management presented virtually at the H.C. Wainwright Global Life Sciences Conference , which took place March 9-10, 2021. The presentation by Bionano CEO Dr. Erik Holmlin is...

SAN DIEGO, March 09, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, March 23 rd , 2021 at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and year end 2020 and to h...

Anchiano Therapeutics (ANCN) +66%.Second Sight Medical Products (EYES) +38%.OpGen (OPGN) +29% after publication of final study results of Unyvero HPN Panel.Net Element (NETE) +19% on strategic partnership with Mullen technologies.Athene Holding Ltd. (ATH) +18%&#x...

The growing market of gene therapies enhances Illumina's growth prospects. Illumina has a strong balance sheet opening an opportunity to gain exposure to the rising market of personalized medicine without the risk of investing in biotech. The acquisition of Grail capitalizes on th...

SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Praxis Genomics, LLC received DEX Z-codes from Palmetto MolDX for its entire testing menu of laboratory developed tests (LDTs) based on Saphyr. The DEX Z-Code modifier is a unique 5-char...

SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the Cowen 41 st Annual Health Care Conference. Erik Holmlin, PhD, Bionano’s Chief Executive Officer, is scheduled to present on Th...

SAN DIEGO, March 01, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that the 2021 Advances in Genome Biology and Technology (AGBT) meeting will feature presentations from scientists at leading research institutes and hospitals including Boston Children’...

An increasing number of scientists now realize the limitations of gene-sequencing in clinical diagnostics, opening an opportunity for growth, highlighted by the rising number of Saphyr mentions in academic publications. Recent technological advancements in the gene-editing arena bode ...

SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication in Science of a study by the Human Genome Structural Variation Consortium (HGSVC) that used a combination of advanced sequencing and optical genome mapping (OGM) with Saphyr to a...